Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Orthofix Medical Inc. - Common Stock
(NQ:
OFIX
)
16.30
-0.46 (-2.74%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Orthofix Medical Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022
April 28, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces New Business Unit President
April 08, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System
March 16, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022
March 04, 2022
Upgrades According to Susquehanna, the prior rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) was changed from Neutral to Positive. Knight-Swift earned $1.61 in the...
Via
Benzinga
Orthofix Medical Earnings Perspective: Return On Capital Employed
February 28, 2022
Benzinga Pro data, Orthofix Medical (NASDAQ:OFIX) reported Q4 sales of $125.06 million. Earnings fell to a loss of $32.81 million, resulting in a 1411.38% decrease from last...
Via
Benzinga
Recap: Orthofix Medical Q4 Earnings
February 25, 2022
Orthofix Medical (NASDAQ:OFIX) reported its Q4 earnings results on Friday, February 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
February 25, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Earnings Scheduled For February 25, 2022
February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...
Via
Benzinga
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
February 22, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25, 2022
February 10, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems
January 19, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results
January 10, 2022
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Appointment of Thomas A. West to Board of Directors
December 14, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Medical's Return on Invested Capital Overview
November 08, 2021
Benzinga Pro data, Orthofix Medical (NASDAQ:OFIX) reported Q3 sales of $112.43 million. Earnings fell to a loss of $313.00 thousand, resulting in a 107.34% decrease from last...
Via
Benzinga
Orthofix Medical inc (OFIX) Q3 2021 Earnings Call Transcript
November 05, 2021
OFIX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
November 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...
Via
Benzinga
Exposures
COVID-19
Product Safety
Orthofix Reports Third Quarter 2021 Results
November 05, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Earnings Scheduled For November 5, 2021
November 05, 2021
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter. • Healthcare Trust (NYSE:HTA) is...
Via
Benzinga
Orthofix Announces Participation in Upcoming Credit Suisse and Stifel Healthcare Conferences
November 03, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 5, 2021
October 27, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Provides Business Update
September 29, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Milestone − More Than 60,000 M6-C Artificial Cervical Discs Implanted Worldwide
September 27, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Appointment of Wayne Burris to Board of Directors
September 23, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures
September 21, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
September 20, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Medical's Return on Invested Capital Insights
September 09, 2021
According to Benzinga Pro, during Q2, Orthofix Medical (NASDAQ:OFIX) earned $4.27 million, a 246.33% increase from the preceding quarter. Orthofix Medical also posted a total of $...
Via
Benzinga
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
September 01, 2021
From
Orthofix Medical Inc.
Via
Business Wire
Orthofix Medical inc (OFIX) Q2 2021 Earnings Call Transcript
August 06, 2021
OFIX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook
August 06, 2021
Orthofix Medical Inc (NASDAQ: OFIX) reported Q2 adjusted EPS $0.32, compared to an adjusted net loss of $(0.59) a year ago, beating the consensus of $0.11. Sales...
Via
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.